Clinical Trials on Relapsed or Refractory Hematologic Malignancies
Total 8508 results
-
CASI Pharmaceuticals, Inc.CompletedRelapsed or Refractory Hematological MalignanciesCanada
-
Shandong UniversityJuventas Cell Therapy Ltd.UnknownRelapsed or Refractory Hematological MalignanciesChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory Hematological MalignanciesChina
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.AvailableRelapsed and Refractory Hematological MalignanciesChina
-
Sinocelltech Ltd.RecruitingRelapsed or Refractory Hematologic MalignanciesChina
-
Vanda PharmaceuticalsUnknownRelapsed or Refractory Hematologic MalignanciesUnited States
-
He HuangYake Biotechnology Ltd.RecruitingRelapsed and Refractory | Lymphoid Hematological MalignanciesChina
-
University of Illinois at ChicagoRecruitingRelapsed or Refractory Hematologic MalignanciesUnited States
-
Sunshine Lake Pharma Co., Ltd.Active, not recruitingRelapsed or Refractory B-cell Hematologic MalignanciesChina
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Lymphoid MalignanciesUnited States
-
The Affiliated People's Hospital of Ningbo UniversityUTC Therapeutics Inc.RecruitingLymphoma | Leukemia | Myeloma | Relapsed/Refractory Hematological MalignanciesChina
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Peking University People's Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsRecruitingCD7-positive Relapsed/Refractory Lymphoid Hematologic MalignanciesChina
-
Affiliated Hospital to Academy of Military Medical...Beijing JD Biotech Co. LTD.RecruitingAdult Relapsed/Refractory B-cell Hematologic MalignanciesChina
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Anhui Provincial HospitalNot yet recruitingCD19-positive Relapsed or Refractory B-cell MalignanciesChina
-
Kai Lin Xu; Jun Nian ZhengiCarTAB BioMed Inc.UnknownRecurrent or Refractory B Cell MalignancyChina
-
Acrotech Biopharma Inc.Axis Clinicals LimitedTerminatedRelapsed/Refractory Solid Tumors/Hematological MalignanciesUnited States
-
St. Jude Children's Research HospitalRecruitingRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...RecruitingRefractory or Recurrent CD30+ Hematologic MalignanciesChina
-
Curon Biopharmaceutical (Australia) Co Pty LtdNovotech (Australia) Pty LimitedTerminatedRelapsed Lymphoid Malignancies | Refractory Lymphoid MalignanciesAustralia
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
iCell Gene TherapeuticsiCar Bio TherapeuticsNot yet recruitingHigh Risk Hematologic Malignancies | Relapsed and/or Refractory Acute Myeloid LeukemiaChina
-
Association for Training, Education, and Research...Active, not recruitingRefractory or Relapsed Lymphoid HaemopathyFrance
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedMetastatic Solid Tumors, Refractory/Relapsed Hematologic MalignanciesUnited States
-
Haisco Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory B-Cell MalignanciesChina, Australia
-
Minghui Pharmaceutical (Shanghai) LTDRecruitingRelapsed/Refractory B-cell MalignanciesChina
-
Gilead SciencesCompletedRelapsed/Refractory B-cell MalignanciesFrance, United Kingdom
-
National Taiwan University HospitalNot yet recruitingRelapsed/Refractory B-Cell Malignancies
-
Catherine BollardJohns Hopkins University; Children's National Research InstituteRecruitingRelapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDSUnited States
-
University Hospital TuebingenLudwig-Maximilians - University of Munich; University Hospital AugsburgCompletedRelapse of Hematological Malignancies
-
Assistance Publique Hopitaux De MarseilleRecruitingCancer and / or Hematological MalignancyFrance
-
Tel-Aviv Sourasky Medical CenterMeir Medical Center; Max Planck Institute for Infection BiologyUnknownPediatric Solid Malignancies | Pediatric Hematological MalignanciesIsrael
-
Princess Maxima Center for Pediatric OncologyRecruitingRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyNetherlands
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
He HuangGracell Biotechnology Ltd.Not yet recruitingRelapsed and Refractory | Lymphoid Hematological MalignanciesChina
-
Hangzhou Sumgen Biotech Co., Ltd.Active, not recruitingRelapsed or Refractory Multiple Myeloma | Hematological MalignancyChina
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineCompletedMyeloid Hematological MalignanciesUnited States
-
Centre Hospitalier Universitaire de BesanconTerminatedHematological Malignancies BFrance
-
AdaptimmuneTerminatedSolid and Hematological MalignanciesUnited States, Canada
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
AstraZenecaParexelCompletedSolid and Hematological MalignanciesGermany
-
Medical College of WisconsinCompletedMalignancies, HematologicUnited States
-
Nanjing Chia-tai Tianqing PharmaceuticalRecruitingRelapsed/Refractory Acute Myeloid Leukemia (AML)China
-
University of California, DavisCompletedHematologic MalignanciesUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingAdvanced Solid Tumors and Hematological Malignancies
-
Constellation PharmaceuticalsCompletedSolid Tumor | Advanced Malignancies | Hematological MalignancySpain, United States, Georgia
-
iOMEDICO AGBristol-Myers Squibb; Roche Pharma AGCompletedAdvanced Solid Tumors or Hematologic MalignanciesGermany
-
Curis, Inc.RecruitingRelapsed Primary Central Nervous System Lymphoma | Refractory Hematologic Malignancy | Relapsed Hematologic Malignancy | Refractory Primary Central Nervous System LymphomaUnited States, Spain, France, Czechia, Israel, Italy, Poland
-
Ascentage Pharma Group Inc.RecruitingAdvanced Solid Tumors or Hematologic MalignanciesUnited States